Douglas E. Coltharp, EVP & Chief Financial Officer, has demonstrated a clear selling bias in his recent insider transactions, primarily involving Encompass Health Corporation (EHC). Over 24 reported trades across two companies, his total sell transactions amounted to $5.84 million, significantly outweighing his $2.55 million in buys. The bulk of his activity centers on EHC, with notable sales including a $1.79 million transaction on February 19, 2026, followed by a $1.57 million sale on February 23, 2026, and a $1.33 million disposition on March 2, 2026. Smaller but consistent sales occurred throughout early 2026, such as $71,814.70 and $83,714.88 in late February. His buying activity was limited to two major acquisitions: a $1.22 million purchase on March 4, 2025, and another $1.32 million buy nearly a year later on March 2, 2026.
Coltharp’s trading in Under Armour (UA) appears minimal, with only four filings since 2025, all marked as derivative transactions with no reported dollar value. His EHC transactions, however, reveal a pattern of periodic, high-value sales interspersed with occasional large purchases. The absence of recent buys or sells in 2026 beyond March suggests a potential pause in activity, though his historical trades indicate a tendency to liquidate holdings systematically. The data reflects a disciplined approach, with sales often clustered in short windows—such as three transactions totaling over $3.5 million within a week in February 2026—while buys are more isolated and infrequent.
AI-assisted summary